|
Volumn 14, Issue 8, 2008, Pages 812-813
|
Predicting the future for people with lung cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
DNA;
GEMCITABINE;
PACLITAXEL;
RNA;
CANCER ADJUVANT THERAPY;
CANCER DIAGNOSIS;
CANCER RISK;
CANCER SURVIVAL;
CANCER THERAPY;
DIAGNOSTIC ACCURACY;
DNA POLYMORPHISM;
GENE SEQUENCE;
HUMAN;
LUNG ADENOCARCINOMA;
LUNG CANCER;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SHORT SURVEY;
TUMOR BIOPSY;
ADENOCARCINOMA;
BIOLOGICAL MARKERS;
GENE EXPRESSION PROFILING;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
LUNG NEOPLASMS;
MEDICAL ONCOLOGY;
MICRORNAS;
POLYMORPHISM, GENETIC;
PROGNOSIS;
RNA, MESSENGER;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 49149104156
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0808-812 Document Type: Short Survey |
Times cited : (30)
|
References (12)
|